Results 121 to 130 of about 5,863 (219)

Virology [PDF]

Avian influenza viruses, notably H5 subtype viruses, pose a continuous threat to public health due to their pandemic potential. In recent years, influenza virus H5 subtype split vaccines with novel oil-in-water emulsion based adjuvants (e.g.

core   +3 more sources

Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003 [PDF]

, 2011
The prevalence of cytomegalovirus (CMV) infections ranges between 50% and 85% in adults in the United States, and its epidemiology varies in different regions of the world and between socioeconomic and age groups.
Freitas, Maria Graça, Lopo, Sílvia, Nogueira, Paulo, Paixão, Maria Teresa, Palminha, Paula, Vinagre, Elsa   +5 more
core   +1 more source

MF59-based lipid nanocarriers for paclitaxel delivery: optimization and anticancer evaluation

Scientific Reports
Breast cancer is the most common invasive cancer in women worldwide, necessitating innovative therapeutic strategies to enhance treatment efficacy and safety.
Marzieh Attar, Fatemeh Tash Shamsabadi, Alireza Soltani, Mohammad Taghi Joghataei, Seyed Reza khandoozi, Shahram Teimourian, Majid Shahbazi, Vahid Erfani-Moghadam   +7 more
doaj   +1 more source

Correlation of influenza infection with glycan array [PDF]

, 2012
Poster Presentation: SPB1 / SPB2 - Virus Host Interaction/Pathogensis/Transmission: abstract no. B109PINTRODUCTION: The past 6 years has seen the introduction of glycan arrays containing large numbers of sialic acid (Sia) containing compounds and these ...
Air, G, Chan, M, Chan, RWY, Dell, A, Haslam, S, Li, ACL, Nicholls, J, Peiris, JSM, Walther, T, Yen, HL   +9 more
core  

The potential for a protective vaccine for rhinovirus infections. [PDF]

, 2016
Glanville, NS, Johnston, SL, Kubajewska, I, Mclean, GR, Williams, GR   +4 more
core   +2 more sources

Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice. [PDF]

Oncotarget, 2017
Ou H, Yao W, Yu D, Weng T, Wang FXC, Wu X, Wu H, Cheng L, Lu X, Wu N, Chen H, Li L, Yao H.   +12 more
europepmc   +1 more source

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus

Frontiers in Immunology, 2023
Mallory L. Myers, John R. Gallagher, De’Marcus D. Woolfork, Regan K. Stradtmann-Carvalho, Samantha Maldonado-Puga, Kevin W. Bock, Seyhan Boyoglu-Barnum, Hubza Syeda, Adrian Creanga, Derron A. Alves, Masaru Kanekiyo, Audray K. Harris   +11 more
doaj   +1 more source

Evaluation of Polymyxin B as a Novel Vaccine Adjuvant and Its Immunological Comparison with FDA-Approved Adjuvants. [PDF]

Vaccines (Basel)
Gulani M, Harsoda Y, Arte T, D'Souza MJ, Bagwe P, Adediran E, D'Souza N, Pasupuleti D.   +7 more
europepmc   +1 more source

Comparison of Adjuvant Potency of Alum, AddaVax, and ISA 71 VG on the Seasonal Split Influenza Vaccine in Mice. [PDF]

Microorganisms
Wu L, Yang R, Wu H, Yang B, Zhang X, Tao Y, Wu X, Li S, Shu J, He Y, Feng H.   +10 more
europepmc   +1 more source

Accelerating Vaccine Adjuvant Screening: Early Follicular Dendritic Cell and Germinal Center B Cell Biomarkers Predict Protective Efficacy. [PDF]

Vaccines (Basel)
Zhong Y, Chen M, Lin H, Liu Z, Zhang S, He Y, Wang B.   +6 more
europepmc   +1 more source